 Severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 has caused an unprecedented global pandemic since its discovery in December 2019. Diagnosis of SARS-CoV-2 has been primarily achieved through the use of reverse transcription polymerase chain reaction, RT-PCR, which has proven to be highly sensitive but also time-consuming and expensive. Recent advances in biotechnology have led to the development of new nucleic acid tests, NATS, that can detect SARS-CoV-2 with greater accuracy and speed than RT-PCR. These NATS offer the potential to be used as a point of care test, reducing the need for laboratory facilities and allowing for faster diagnoses. This article was authored by Sikandar Hayat Khan, Sabine Kurshade-Zady, and Marine Jelani.